Research Article

Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study

Table 1

Pathology results by fecal immunochemical test value.

10–14.9 μg/g
(50–74 ng/mL)
(/%)
15–19.9 μg/g
(75–99 ng/mL)
(/%)
20–39.9 μg/g
(100–199 ng/mL)
(/%)
40–99.9 μg/g
(200–499 ng/mL)
(/%)
≥100 μg/g
(≥500 ng/mL)
(/%)
Total
(/%)

CRC40 (0.6)21 (0.7)44 (1.1)102 (3.2)242 (8.4)449 (2.3)
HRA836 (12.6)464 (15.8)801 (19.8)802 (25.4)1109 (38.4)4012 (20.4)
MLRA401 (6.0)188 (6.4)263 (6.5)189 (6.0)132 (4.6)1173 (6.0)
LRA1857 (28.0)813 (27.7)1112 (27.5)773 (24.5)474 (16.4)5029 (25.6)
No neoplasia3507 (52.8)1444 (49.3)1824 (45.1)1292 (40.9)930 (32.2)8997 (45.8)
Total6641293040443158288719660

CRC, colorectal cancer; HRA, high-risk adenoma; LRA, low-risk adenoma; MLRA, multiple low-risk adenomas.